TBI prior to adoptive cell transfer added harm, no benefit
Matrilin-2 protein distinguished BCCs from benign tumors in study
For preventing AKs, 5-FU beats placebo for up to 3 years
Immune-related patterns of response present challenges
Point/Counterpoint: What is the first-line treatment of choice for metastatic BRAF-mutant melanoma?
Mini X-Ray Device Treats Nonmelanoma Skin Cancers
Patient ResourcesMore ›
Decision Support in Medicine: Melanoma
VIDEO: Genetic tests, clinical data sharpen pigmented lesion diagnosis
VIDEO: New microscopy tools improve melanoma detection
VIDEO: Dual immunotherapy more powerful in melanoma, but where do we go from here?